Last reviewed · How we verify
NCT05421728: ENACT
Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease
NA trial testing ENACT group visit in Advance Care Planning in 516 participants. Participants enrolled and being followed up; not accepting new ones.
1 May 2027
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 516 |
| Start date | 26 July 2022 |
| Primary completion | 1 May 2027 |
| Estimated completion | 1 May 2027 |
| Sites | 8 locations across United States |
Drugs / interventions tested
- ENACT group visit
- Mailed Resources
Conditions studied
- Advance Care Planning — all drugs for Advance Care Planning →
- Primary Health Care — all drugs for Primary Health Care →
Sponsor
University of Colorado, Denver
Who can join
18 and older, any sex, with Advance Care Planning or Primary Health Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main goal of the ENACT (ENgaging in Advance Care planning Talks) Group Visit intervention is to integrate a patient-centered advance care planning process into primary care, ultimately helping patients to receive medical care that is aligned with their values. The ENACT Group Visit intervention involves two group discussions about advance care planning with 8-10 patients who meet for 2-hour sessions, one month apart, facilitated by a geriatrician and a social worker. This study will compare the ENACT Group Visit intervention to mailed advance care planning materials.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Overcoming Barriers to Engaging Latino Older Adults in an Advance Care Planning Clinical Trial: Perspectives for Researchers and Funders.
Farro SA, Mino I, Lum HD, Kielty T, et al · · 2026 · PMID 41173512 · DOI 10.1177/10966218251391030 -
Engaging English- and Spanish-speaking older adults with and without possible cognitive impairment in advance care planning group visits: protocol for the ENgaging in Advance Care Planning Talks (ENACT) randomized controlled trial.
Farro SA, Juarez-Colunga E, Patel C, Bettcher BM, et al · · 2025 · PMID 40999430 · DOI 10.1186/s13063-025-08964-x -
Engaging English- and Spanish-speaking older adults with and without possible cognitive impairment in advance care planning group visits: Protocol for the ENgaging in Advance Care Planning Talks (ENACT) Randomized Controlled Trial
Lum H, Farro S, Juarez-Colunga E, Patel C, et al · · 2025 · DOI 10.21203/rs.3.rs-6560971/v1
Verify or expand the search:
- PubMed search for NCT05421728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ENACT group visit
Trials testing the same drug.
- NCT03141242 — ENgaging in Advance Care Planning Talks Group Visit Intervention · NA · completed
Other recruiting trials for Advance Care Planning
Currently open trials in the same condition.
- NCT07235839 — The Impact of an Advance Care Planning Game on Life-Sustaining Treatment Preferences, Depression, and Hope in Older Adul · NA · active not recruiting
- NCT07134881 — Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE) · NA · recruiting
- NCT06538493 — Jumpstarting Advance Care Planning With ANAI People · NA · recruiting
- NCT06731361 — Improved Prescribing for Older Nursing Home Patients · NA · recruiting
- NCT06376799 — Which Health-care Professional(s) to Talk About Advance Care Planning ? · recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05421728 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 26 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05421728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing